Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 28

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 3
Chunk 28
---

and may affect the rights of existing shareholders.

We
have been and will continue to seek additional capital through a combination of private and public equity offerings, debt financing and
collaborations and strategic and licensing arrangements. To the extent that we raise additional capital through the issuance of equity
or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that
adversely affect your rights as a holder of our ADSs and ordinary shares.

On
July 16, 2024, we entered into the standby equity purchase agreement (the “ SEPA”), with YA II PN, LTD., (“ Yorkville”),
pursuant to which Yorkville has committed to purchase up to $15.0 million of our ADSs at our direction from time to time during
3-year period following the date of the execution, until July 16, 2027 of the SEPA, subject to the restrictions and satisfaction of the
conditions in the SEPA. Yorkville advanced to the Company the principal amount of $3,000,000 (the “ Pre-Paid Advance”),
evidenced by the Promissory Notes, which are convertible into Company’s ADSs. Unless converted by Yorkville or redeemed by the
Company. the principal, interest and any other payments due under the Promissory Notes shall be paid in cash on January 16, 2026.

As
of the date of this report, we have sold and issued an aggregate of 445,803,290 ordinary
shares represented by 371,503 ADSs (after giving retroactive effect to the new ratio of 1,200
ordinary shares for each ADS) to YA as Advance Shares for aggregate gross proceeds of approximately
$5.84 million. The purchase price for the ADSs that we may sell to YA will fluctuate based
on the price of our ADSs. Depending on market liquidity at the time, sales of such ADSs may
cause the trading price of our ADSs to fall. After YA has acquired the ADSs, YA may resell
all, some, or none of those shares at any time or from time to time in its discretion. Therefore,
our sales to YA could result in substantial dilution to the interests of other
holders of our ordinary shares and ADSs. Additionally, the sale of a substantial number of
shares of our ADSs to YA, or the anticipation of such sales, could make it more difficult
for us to sell equity